Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (651-660 of 743) with videos related to

Pageof 75
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Benchmarking of a multi-biomarker low-volume panel for Alzheimer's Disease and related dementia researchLaura Ibanez, Menghan Liu, Aleksandra Beric, et al.
Cell|October 28, 2022
TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathwaysShoutang Wang, Raki Sudan, Vincent Peng, et al.
Science Translational Medicine|April 26, 2023
Sleep deprivation exacerbates microglial reactivity and Aβ deposition in a <i>TREM2</i>-dependent manner in miceSamira Parhizkar, Grace Gent, Yun Chen, et al.
Annals of Neurology|July 4, 2024
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis PatientsMatthew R Brier, Suzanne E Schindler, Amber Salter, et al.
Science (New York, N.Y.)|August 1, 2024
Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogrammingZhao Sun, Ji-Sun Kwon, Yudong Ren, et al.
Alzheimer Disease and Associated Disorders|April 30, 2016
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal IndividualsCatherine M Roe, Peggy P Barco, Denise M Head, et al.
Plos Genetics|September 24, 2010
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Kevin Mayo, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Endogenous recapitulation of Alzheimer's disease neuropathology through human 3D direct neuronal reprogrammingZhao Sun, Ji-Sun Kwon, Yudong Ren, et al.
JAMA Neurology|May 12, 2025
Lecanemab Treatment in a Specialty Memory ClinicMadeline Paczynski, Anna Hofmann, Zachary Posey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2024
Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia researchLaura Ibanez, Menghan Liu, Aleksandra Beric, et al.
Pageof 75

Showing results (651-660 of 743) with videos related to

Sort By:
Pageof 75
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Benchmarking of a multi-biomarker low-volume panel for Alzheimer's Disease and related dementia researchLaura Ibanez, Menghan Liu, Aleksandra Beric, et al.
Cell|October 28, 2022
TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathwaysShoutang Wang, Raki Sudan, Vincent Peng, et al.
Science Translational Medicine|April 26, 2023
Sleep deprivation exacerbates microglial reactivity and Aβ deposition in a <i>TREM2</i>-dependent manner in miceSamira Parhizkar, Grace Gent, Yun Chen, et al.
Annals of Neurology|July 4, 2024
Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis PatientsMatthew R Brier, Suzanne E Schindler, Amber Salter, et al.
Science (New York, N.Y.)|August 1, 2024
Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogrammingZhao Sun, Ji-Sun Kwon, Yudong Ren, et al.
Alzheimer Disease and Associated Disorders|April 30, 2016
Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal IndividualsCatherine M Roe, Peggy P Barco, Denise M Head, et al.
Plos Genetics|September 24, 2010
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Kevin Mayo, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Endogenous recapitulation of Alzheimer's disease neuropathology through human 3D direct neuronal reprogrammingZhao Sun, Ji-Sun Kwon, Yudong Ren, et al.
JAMA Neurology|May 12, 2025
Lecanemab Treatment in a Specialty Memory ClinicMadeline Paczynski, Anna Hofmann, Zachary Posey, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2024
Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia researchLaura Ibanez, Menghan Liu, Aleksandra Beric, et al.
Pageof 75